GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW 638.00
-56.00 (-8.07%)
Last updated: Jun 22, 2026, 1:36 PM KST
GeneOne Life Science Market Cap
GeneOne Life Science has a market cap or net worth of 62.93 billion as of June 18, 2026. Its market cap has decreased by -77.92% in one year.
Market Cap
62.93B
Enterprise Value
91.36B
Revenue
17.12B
Ranking
n/a
PE Ratio
n/a
Stock Price
638.00
Market Cap Chart
Since August 30, 1995, GeneOne Life Science's market cap has increased from 3.40B to 62.93B, an increase of 1,750.81%. That is a compound annual growth rate of 9.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 62.93B | -62.30% |
| Dec 30, 2025 | 166.91B | -1.14% |
| Dec 30, 2024 | 168.84B | -24.04% |
| Dec 28, 2023 | 222.27B | -59.85% |
| Dec 29, 2022 | 553.65B | -55.74% |
| Dec 30, 2021 | 1.25T | 30.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 125.52B |
| MedPacto | 115.16B |
| Vaxcell-Bio Therapeutics | 106.63B |
| Amicogen | 106.60B |
| ENCell | 91.43B |
| iNtRON Biotechnology | 84.09B |
| Prestige BioPharma | 79.21B |
| CG Invites | 79.20B |